Skip to main content
# Title Research Member Research Year
71 Prognostic Significance of Absolute
Lymphocytic Count Recovery in Pediatric
Patients with Acute Lymphoblastic Leukemia at
South Egypt Cancer Institute
Prof. Heba Abdel-Razik Sayed Hussein 2019
72 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom
Prof. Amany Mohamed Ali Ahmed 2018
73 Flowcytometric CD135 Expression
and its Impact on Pediatric Acute
Lymphoblastic Leukemia at South Egypt
Cancer Institute
Prof. Heba Abdel-Razik Sayed Hussein 2018
74 HCMV Among Pediatrics Acute Lymphoblastic Leukemia Patients in South Egypt Cancer Institute Dr. Khaled Fathy Riad Osman 2018
75 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom Dr. Amira Mahmoud Mohammed Osman 2018
76 Nutritional Assessment and Intervention Methods in Children at Pediatric Oncology Department Mohammed Zakrya Ahmed Saleh 2018
77 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom Prof. Amany Mohamed Ali Ahmed 2018
78 Risk-Adapted, Combined-Modality Therapy for
Unfavorable Pediatric Hodgkin Lymphom
Prof. Amany Mohamed Ali Ahmed 2018
79 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom Dr. Tarek Mohamed Abdel Moneim Mohamed Elsaba Ahmed 2018
80 Flowcytometric CD135 Expression
and its Impact on Pediatric Acute
Lymphoblastic Leukemia at South Egypt
Cancer Institute
Dr. Azaa Shibl Sayed Mahmoud 2018